AI assistant
Sending…
CLOROX CO /DE/ — Director's Dealing 2022
Jan 4, 2022
30403_dirs_2022-01-04_ff09c478-f6cb-4e8d-a5bf-2dc07140eb4d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2021-12-31
Reporting Person: Tesija Kathryn A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-10 | Deferred Stock Units | $ | A | 8.0269 | Acquired | Common Stock (8.0269) | Direct | |
| 2021-12-31 | Deferred Stock Units | $ | A | 918.6024 | Acquired | Common Stock (918.6024) | Direct | |
| 2021-12-31 | Deferred Stock Units | $ | A | 147.6830 | Acquired | Common Stock (147.6830) | Direct |
Footnotes
F1: 1-for-1
F2: Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3: The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4: Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5: Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.
More from CLOROX CO /DE/
Regulatory Filings
2026
Jun 1
Board/Management Information
2026
May 28
Capital/Financing Update
2026
May 11
Regulatory Filings
2026
May 8
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 6
Capital/Financing Update
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29